Cancer’s got nerve: Schwann cells drive perineural invasion

Por Azam, Salma H., Pecot, Chad V.
Publicado no J Clin Invest (2016)

Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment

Por Harrison, Emily B., Azam, Salma H., Pecot, Chad V.
Publicado no Front Pharmacol (2018)

Incorporating Pericytes into an Endothelial Cell Bead Sprouting Assay

Por Azam, Salma H., Smith, Mitchell, Somasundaram, Vivek, Pecot, Chad V.
Publicado no J Vis Exp (2018)

RNA interference in the clinic: challenges and future directions

Por Pecot, Chad V., Calin, George A., Coleman, Robert L., Lopez-Berestein, Gabriel, Sood, Anil K.
Publicado em 2010

Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location

Por Perry, Jillian L., Reuter, Kevin G., Luft, J. Christopher, Pecot, Chad V., Zamboni, William, DeSimone, Joseph M.
Publicado no Nano Lett (2017)

Diagnostic Characteristics of a Serum Biomarker in Patients With Positron Emission Tomography Scans

Por Grogan, Eric L., Deppen, Stephen, Pecot, Chad V., Putnam, Joe B., Nesbitt, Jonathan C., Shyr, Yu, Rajanbabu, Rama, Ory, Bridget, Lambright, Eric S., Massion, Pierre P.
Publicado em 2010

Case Report: Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients with Lung Adenocarcinoma

Por Lou, Yanyan, Pecot, Chad V., Tran, Hai T., DeVito, Vikki J., Tang, Xi Ming, Heymach, John, Luthra, Raja, Wistuba, Ignacio I., Zuo, Zhuang, Tsao, Anne S.
Publicado no Clin Lung Cancer (2015)

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

Por Miret, Juan J., Kirschmeier, Paul, Koyama, Shohei, Zhu, Mingrui, Li, Yvonne Y., Naito, Yujiro, Wu, Min, Malladi, Venkat S., Huang, Wei, Walker, William, Palakurthi, Sangeetha, Dranoff, Glenn, Hammerman, Peter S., Pecot, Chad V., Wong, Kwok-Kin, Akbay, Esra A.
Publicado no J Immunother Cancer (2019)

Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β–induced Serpine1

Por McCann, James V., Xiao, Lin, Kim, Dae Joong, Khan, Omar F., Kowalski, Piotr S., Anderson, Daniel G., Pecot, Chad V., Azam, Salma H., Parker, Joel S., Tsai, Yihsuan S., Wolberg, Alisa S., Turner, Stephen D., Tatsumi, Kohei, Mackman, Nigel, Dudley, Andrew C.
Publicado no J Clin Invest (2019)

Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules

Por Pecot, Chad V., Li, Ming, Zhang, Xueqiong J., Rajanbabu, Rama, Calitri, Ciara, Bungum, Aaron, Jett, James R., Putnam, Joe B., Callaway-Lane, Carol, Deppen, Steve, Grogan, Eric L., Carbone, David P., Worrell, John A., Moons, Karel G.M., Shyr, Yu, Massion, Pierre P.
Publicado em 2012

Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer

Por Kang, Yu, Hu, Wei, Ivan, Cristina, Dalton, Heather J., Miyake, Takahito, Pecot, Chad V., Zand, Behrouz, Liu, Tao, Huang, Jie, Jennings, Nicholas B., Rupaimoole, Rajesha, Taylor, Morgan, Pradeep, Sunila, Wu, Sherry Y., Lu, Chunhua, Wen, Yunfei, Huang, Jianfei, Liu, Jinsong, Sood, Anil K.
Publicado em 2013

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

Por Yang, Da, Sun, Yan, Hu, Limei, Zheng, Hong, Ji, Ping, Pecot, Chad V., Zhao, Yanrui, Reynolds, Sheila, Cheng, Hanyin, Rupaimoole, Rajesha, Cogdell, David, Nykter, Matti, Broaddus, Russell, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Liu, Jinsong, Shmulevich, Ilya, Sood, Anil K., Chen, Kexin, Zhang, Wei
Publicado em 2013

Differential platelet levels affect response to taxane-based therapy in ovarian cancer

Por Bottsford-Miller, Justin, Choi, Hyun-Jin, Dalton, Heather J., Stone, Rebecca L., Cho, Min Soon, Haemmerle, Monika, Nick, Alpa M., Pradeep, Sunila, Zand, Behrouz, Previs, Rebecca A., Pecot, Chad V., Crane, Erin King, Hu, Wei, Lutgendorf, Susan K., Afshar-Kharghan, Vahid, Sood, Anil K.
Publicado no Clin Cancer Res (2014)

Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers

Por Liu, Guoyan, Yang, Da, Rupaimoole, Rajesha, Pecot, Chad V., Sun, Yan, Mangala, Lingegowda S., Li, Xia, Ji, Ping, Cogdell, David, Hu, Limei, Wang, Yingmei, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Shmulevich, Ilya, De Cecco, Loris, Chen, Kexin, Mezzanzanica, Delia, Xue, Fengxia, Sood, Anil K., Zhang, Wei
Publicado no J Natl Cancer Inst (2015)

Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

Por Lee, Sun Joo, Ghosh, Sukhen C., Han, Hee Dong, Stone, Rebecca L., Bottsford-Miller, Justin, Shen, De Yue, Auzenne, Edmond J., Lopez-Araujo, Alejandro, Lu, Chunhua, Nishimura, Masato, Pecot, Chad V., Zand, Behrouz, Thanapprapasr, Duangmani, Jennings, Nicholas B, Kang, Yu, Huang, Jie, Hu, Wei, Klostergaard, Jim, Sood, Anil K.
Publicado em 2012

A genome‐scale screen reveals context‐dependent ovarian cancer sensitivity to miRNA overexpression

Por Shields, Benjamin B, Pecot, Chad V, Gao, Hua, McMillan, Elizabeth, Potts, Malia, Nagel, Christa, Purinton, Scott, Wang, Ying, Ivan, Cristina, Kim, Hyun Seok, Borkowski, Robert J, Khan, Shaheen, Rodriguez‐Aguayo, Cristian, Lopez‐Berestein, Gabriel, Lea, Jayanthi, Gazdar, Adi, Baggerly, Keith A, Sood, Anil K, White, Michael A
Publicado no Mol Syst Biol (2015)

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER

Por van den Beucken, Twan, Koch, Elizabeth, Chu, Kenneth, Rupaimoole, Rajesha, Prickaerts, Peggy, Adriaens, Michiel, Voncken, Jan Willem, Harris, Adrian L., Buffa, Francesca M., Haider, Syed, Starmans, Maud H.W., Yao, Cindy Q., Ivan, Mircea, Ivan, Cristina, Pecot, Chad V., Boutros, Paul C., Sood, Anil K., Koritzinsky, Marianne, Wouters, Bradly G.
Publicado no Nat Commun (2014)

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression

Por Rupaimoole, Rajesha, Ivan, Cristina, Yang, Da, Gharpure, Kshipra M., Wu, Sherry Y., Pecot, Chad V., Previs, Rebecca A., Nagaraja, Archana S., Armaiz-Pena, Guillermo N, McGuire, Michael, Pradeep, Sunila, Mangala, Lingegowda S., Rodriguez-Aguayo, Cristian, Huang, Li, Bar-Eli, Menashe, Zhang, Wei, Lopez-Berestein, Gabriel, Calin, George A., Sood, Anil K.
Publicado no Oncogene (2016)

Crosstalk between EphA2 and BRaf/CRaf is a Key Determinant of Response to Dasatinib

Por Huang, Jie, Hu, Wei, Bottsford-Miller, Justin, Liu, Tao, Han, Hee Dong, Zand, Behrouz, Pradeep, Sunila, Roh, Ju-Won, Thanapprapasr, Duangmani, Dalton, Heather J., Pecot, Chad V., Rupaimoole, Rajesh, Lu, Chunhua, Fellman, Bryan, Urbauer, Diana, Kang, Yu, Jennings, Nicholas B., Huang, Li, Deavers, Michael T., Broaddus, Russell, Coleman, Robert L., Sood, Anil K.
Publicado em 2014

Therapeutic Silencing of KRAS using Systemically Delivered siRNAs

Por Pecot, Chad V., Wu, Sherry Y., Bellister, Seth, Filant, Justyna, Rupaimoole, Rajesha, Hisamatsu, Takeshi, Bhattacharya, Rajat, Maharaj, Anshumaan, Azam, Salma, Rodriguez-Aguayo, Cristian, Nagaraja, Archana S., Morelli, Maria Pia, Gharpure, Kshipra M., Waugh, Trent A., Gonzalez-Villasana, Vianey, Zand, Behrouz, Dalton, Heather J., Kopetz, Scott, Lopez-Berestein, Gabriel, Ellis, Lee M., Sood, Anil K.
Publicado no Mol Cancer Ther (2014)